Importantly, the ex vivo screen also demonstrated that protein kinase inhibitors targeting JAK1, JAK2, aurora A, IGF1R and PLK suppressed cell growth of IR MCL cells (Fig. 6e). Here, PLK1 is linked to mantle cell lymphoma.